105 related articles for article (PubMed ID: 1676026)
21. Restriction fragment length polymorphism analysis of HLA haplotypes in families with type I diabetes mellitus.
Badenhoop K; Schwarz G; Bingley P; Lewis V; Drummond V; Gale EA; Bottazzo GF
Tissue Antigens; 1990 Jan; 35(1):32-9. PubMed ID: 1968292
[TBL] [Abstract][Full Text] [Related]
22. Segregation of HLA-DR, -DQ and -DP phenotypes and restriction fragment length polymorphic fragments in two recombinant families.
Munck Petersen C; Juncker Sørensen I; Hyldig-Nielsen JJ; Lamm LU
Tissue Antigens; 1988 Aug; 32(2):104-11. PubMed ID: 2904184
[TBL] [Abstract][Full Text] [Related]
23. PCR-SSO typing for HLA-DRB alleles.
Vaughan RW
Eur J Immunogenet; 1991; 18(1-2):69-80. PubMed ID: 1676912
[TBL] [Abstract][Full Text] [Related]
24. Discrepancies in serological tissue typing revealed by DNA techniques.
Middleton D; Savage DA; Cullen C; Martin J
Transpl Int; 1988 Oct; 1(3):161-4. PubMed ID: 2908097
[TBL] [Abstract][Full Text] [Related]
25. Identification of HLA-DRw52 associated antigens using HLA class II allogenotyping.
Savage DA; Bidwell JL; Cullen C; Bidwell EA; Middleton D
Tissue Antigens; 1988 Nov; 32(5):278-85. PubMed ID: 2464859
[TBL] [Abstract][Full Text] [Related]
26. A monoclonal antibody with broad anti-HLA-DR activity fails to bind to DRw11/Dw5: possible effect of a unique polymorphism on the beta 1 domain alpha-helix.
Mackworth-Young CG; Kevany M; Lombardi G; Sidhu S; Sharrock C; Batchelor JR; Lechler RI
Hum Immunol; 1991 Mar; 30(3):174-82. PubMed ID: 2055782
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of a recombinant HLA-DR1/DR2 haplotype.
Bidwell JL; Bidwell EA; Dupont E; Andrien M; Bouillenne C; Klouda PT; Bradley BA
Hum Immunol; 1992 Apr; 33(4):289-93. PubMed ID: 1353488
[TBL] [Abstract][Full Text] [Related]
28. Familial IgA nephropathy: a study of HLA class II allogenotypes in a Chinese kindred.
Li PK; Burns AP; So AK; Lai KN; Rees AJ
Am J Kidney Dis; 1992 Nov; 20(5):458-62. PubMed ID: 1359783
[TBL] [Abstract][Full Text] [Related]
29. HLA class II typing by digestion of PCR-amplified DNA with allele-specific restriction endonucleases will fail to unequivocally identify the genotypes of many homozygous and heterozygous individuals.
Olerup O
Tissue Antigens; 1990 Aug; 36(2):83-7. PubMed ID: 1980163
[TBL] [Abstract][Full Text] [Related]
30. Comparison of HLA-DRB1 typing by DNA-RFLP, PCR-SSO and PCR-SSP methods and their application in providing matched unrelated donors for bone marrow transplantation.
Jordan F; McWhinnie AJ; Turner S; Gavira N; Calvert AA; Cleaver SA; Holman RH; Goldman JM; Madrigal JA
Tissue Antigens; 1995 Feb; 45(2):103-10. PubMed ID: 7792755
[TBL] [Abstract][Full Text] [Related]
31. Application of HLA-DR oligotyping to 110 kidney transplant patients with doubtful serological typing.
Tiercy JM; Goumaz C; Mach B; Jeannet M
Transplantation; 1991 May; 51(5):1110-4. PubMed ID: 1674388
[TBL] [Abstract][Full Text] [Related]
32. Individuals with HLA-DR blank alleles display well-known DR-DQ RFLPs.
Wallin J; Carlsson B; Olerup O; Möller E
Tissue Antigens; 1989 Jul; 34(1):9-16. PubMed ID: 2573170
[TBL] [Abstract][Full Text] [Related]
33. The narcolepsy-associated DRw15,DQw6,Dw2 haplotype has no unique HLA-DQA or -DQB restriction fragments and does not extend to the HLA-DP subregion.
Olerup O; Schaffer M; Hillert J; Sachs C
Immunogenetics; 1990; 32(1):41-4. PubMed ID: 1973684
[TBL] [Abstract][Full Text] [Related]
34. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
[TBL] [Abstract][Full Text] [Related]
35. Definition of DRw10 specificity by restriction fragment length polymorphism.
Semana G; Bignon JD; Quillivic F; Cheneau ML; Herniou E; Muller JY; Genetet B; Fauchet R
Tissue Antigens; 1988 Sep; 32(3):113-20. PubMed ID: 2464202
[TBL] [Abstract][Full Text] [Related]
36. The complexity of DRw6 and DR5 haplotypes in American blacks demonstrated by serology, cellular typing, and restriction fragment length polymorphism analysis.
Lee KW; Hurley CK; Hartzman R; Johnson AH
Hum Immunol; 1990 Nov; 29(3):202-19. PubMed ID: 1980920
[TBL] [Abstract][Full Text] [Related]
37. HLA-DRB and -DBQ typing by PCR amplification using sequence-specific primers (PCR-SSP): assessment after 1 year of routine use by three laboratories.
Mercier B; al Daccak R; Samaan A; David F; Carta A; Cracco P; Raguenes O; Dufosse F; Ferec C; Charron D
Eur J Immunogenet; 1994 Apr; 21(2):105-23. PubMed ID: 9098425
[TBL] [Abstract][Full Text] [Related]
38. RFLP of the HLA-DQ alpha region: a diallelic DX alpha polymorphism, not linked to DR and DQ specificities.
Tilanus MG; Van Eggermond MC; Fei H; D'Amaro J; Schreuder GM; Giphart MJ
Tissue Antigens; 1987 Sep; 30(3):128-34. PubMed ID: 2892281
[TBL] [Abstract][Full Text] [Related]
39. Associations of HLA-DR and HLA-DQ types with anti-GBM nephritis by sequence-specific oligonucleotide probe hybridization.
Huey B; McCormick K; Capper J; Ratliff C; Colombe BW; Garovoy MR; Wilson CB
Kidney Int; 1993 Aug; 44(2):307-12. PubMed ID: 8377374
[TBL] [Abstract][Full Text] [Related]
40. Linkage between rheumatoid arthritis susceptibility and the presence of HLA-DR4 and DR beta allelic third hypervariable region sequences in southern Chinese persons.
Seglias J; Li EK; Cohen MG; Wong RW; Potter PK; So AK
Arthritis Rheum; 1992 Feb; 35(2):163-7. PubMed ID: 1346498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
